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(involving arachidonic acid metabolism) which
regulate macrophage-mediated cytotoxicity
(Schultz) and wtith the effects of irradiation
and cis-diammine dichloroplatinum on spon-
taneous monocyte-nmediated cvtotoxicity
(Muchmore).
In the second section of the book, largely
devoted to modulation of NK activity, the
tracks are indeed well-worn, for this is surely
a topic which has suffered from literarv over-
exposure. Inevitably, the critical experiments
establishing an unequivocal role for NK cells
in surveillance against malignant disease
remain elusive. This is not surprising. since a
plethora of immune and non-immune factors
must be involved in the exercise of host
restraint. Familiarity, however, does not
breed contempt, for there are useful, if repeti-
tive, chapters on enhancement of CTL and
NK activities (Zarling), on natural killer
clones (Dennert) and on in vitro generation
of NK-like activity (Trinchieri), as well as on
enhancement of human NK activity in vivo
by IFN (Einhorn). The book culminates in a
skilful and prudent review of the state of the
art from Herberman.
Having said this, the positive features of
the book are probably insufficient for com-
pulsory purchase by the specialist, for whom
it would have decidedly limited utility. There
is, however, a case for having a series of
articles addressing closely related themes
between the same covers, provided the general
level of scientific acceptability is high, which
this is. Readers will look in vain for data on
IL-2, for such has been the rapidity of
development in this field that the workshop
antedated the impact of IL-2 on current
thinking about the interaction between
adaptive and natural immunity.
M. MOORE
Controversies in Oncology. Ed. P. H.
WIERNIK (1982). Chichester: John Wilev
& Sons. 415 pp. £28.70 net.
This book provides an interesting approach
to the understanding of important controver-
sies in oncology. Each controversial issue is
debated in two chapters by different authors.
each setting out one side of the argument.
The result is an extremely interesting and
easily readable text. The subjects for dis-
cussion have been N-ell selected and cover
imany of the major controversies in haemato-
logic malignancies, adjuvant therapy of solid
tumours, supportive care and certain innova-
tive forms of therapy. Subjects include
combined modality therapy in early-stage
Hodgkin's disease, intensive treatment of
low-grade malignant lymphoma, androgen
therapy in haematologic malignancies, adju-
vant therapy for osteosarcoma and breast
cancer, and tlhe role of protected environ-
ments and granulocyte transfusions for
immunosuppressed patients. Other important
issues which are discussed include the prob-
lems of single-institution studies vs those
of mnulticentre collaborative-group studies.
leading experts on these controversial issues
have been chosen carefully and the clinical
oncologist w-ill find the approach an interest-
ing and informative one.
D. CROWTHER
Cancer-Principles and Practice of
Oncology. V. DE ATITA, JR, S. HELLMAN &
S. A. ROSENBERG (1982). Philadelphia:
Lippincott. 1926 pp. £75.00 net.
This is the most comprehensive textbook
on the principles and practice of oncology
ever w,ritten. Almost all the 104 contributors
are from the U.S.A., but recognized leading
authorities, experts in the principal modalities
of treatment (surgery, radiotherapy, chemo-
therapy) have been Mwell clhosen. Although
this is a textbook for the clinical oncologist,
4 of the 49 clhapters are devoted to relevant
cancer biology, and these make important
contributions. Chapters on the principles of
surgery, radiotherapy, chemotherapy, psy-
chosociology and the design of clinical trials
then follow. The bulk of the text is devoted
to chapters dealing with the natural history,
pathology and treatment of different cancers
bv site. The aim has been to present the
reader with a balanced view of management
problems in treating patients with cancer,
and in this the authors have largely succeeded.
This is an essential textbook for all medical
libraries and an important reference book for
all those studying clinical oncology.
D. CROWATHER
Suppressor Cells in Human Cancer:
Immunology Series Volume 14. Ed.
J. S. GOODWIN (1981). New York: Marcel
Dekker. 363 pp.
Over the last 5 years a vast amount ofMwork
has been published on celluiar mechanismsBOOK REVIEWS 309
capable of suppressing the immune response,
and this is still a very fashionable area of
research. However there are difficulties in
interpreting studies in this area, particularly
due to the diversity of assay systems used by
different investigators, and the use of the
term "suppressor cell" to describe any cell
capable of reducing an immune response,
even when tested under unphysiological
conditions.
This book provides useful reviews of
several major topics concerned with immuno-
regulation, and consists of 12 review articles
by selected authors. The content of the book
is broader than the title suggests, much of
the data concerns experimental animal
models, and several chapters are devoted to
the effects of pharmacological agents rather
than cells.
The book starts with a useful introductory
chapter by Goodwin dealing with the develop-
ment of studies on suppressor cells, their
involvement in tolerance and immuno-
regulation and the nature of the cells respon-
sible. The first half of the book contains
chapters on the possible immunoregulatory
functions of cyclic AMP, prostaglandins and
hormones. There is also an interesting chapter
by Raff and Stobo, in which they discuss the
various levels at which macrophages and
macrophage products can affect lymphocyte
function, and the possible consequences of
macrophage defects. The chapter by Engle-
man concerns the properties of T cells which
show HLA-D restricted suppression of the
MLR and which are apparently found in
increased numbers in the circulation of
patients with Hodgkin's disease.
The second half of the book is primarilv
concerned with evidence for the involvement
of suppressor cells in various disease pro-
cesses, and thereisalso achapter on maternal-
fetal interactions. There are chapters on
rheumatic diseases, immunodeficiency, allergy
and schistosomiasis. In these chapters the
authors present evidence for the multi-
factorial defects found in many disease states,
often involving, suppressor cells, though the
role of suppressor cells and soluble factors in
complex disease processes is still far from
clear.
The final two chapters deal with immuno-
suppression and cancer, the first is a chapter
on suppression by soluble factors produced
by murine tumour cells, and the second a
review of immunodeficiency in cancer, which
covers experimental animals and cancer
patients.
This book will provide useful reading for
those interested in cellular immunology.
However, due to the rapid pace of research
in this field it is likely to be out ofdate within
a very short time.
M. R. POTTER
Lymphocyte Circulation: Experimental
and Clinical Aspects. M. DE SOUSA (1982).
Chichester: John Wiley. 259 Pp. £19.50 net.
Recent years have witnessed an increased,
but far from complete, understanding of the
diversity and functional importance of lym-
phocytes. It is, however, important to retain
an awareness of the physiological framework
within which lymphocytes exert their im-
munological influence. This new book aims
to provide a review of the lymphoid system
and the traffic of lymphocytes within it. The
first chapters examine, with the aid of con-
siderable experimental data, the major
lymphoid organs and the passage of lympho-
cytes within, between and outside them.
Chapter 6 discusses perturbations of lympho-
cyte recirculation and their clinical import-
ance. The following chapter, contributed by
Dr Curtis, considers, with reference to other
biological systems, the complex cellular
interactions which may be involved in
lymphocyte traffic. Finally, in the last chapter
Dr de Sousa concludes by asking how and,
interestingly, why lymphocytes recirculate.
Whilst it cannot be recommended as an
introductory text, this comprehensive and
well-illustrated book will undoubtedly prove
useful to both cellular immunologists and
clinicians with an interest in lymphoid
disease.
I. KIMBER